EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 04 listopada 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikazano 376 - 400 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC	EU_BA Directive 2000/54/EC
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1yl)benzene-1,4-disulfonate	418-270-7	-	Skin Sens. 1			Details
pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate	414-910-4	-	Eye Dam. 1; Skin Sens. 1			Details
Peptostreptococcus anaerobius	-	-			B Bacteria and similar species	Details
Perfluoroheptanoic acid and its salts show/hide Perfluoroheptanoic acid EC / List no: 206-798-9 \| CAS no: 375-85-9 Sodium perfluoroheptanoate EC / List no: 243-518-4 \| CAS no: 20109-59-5 potassium perfluoroheptanoate EC / List no: - \| CAS no: 21049-36-5 Ammonium perfluoroheptanoate EC / List no: 228-098-2 \| CAS no: 6130-43-4	-	-		R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)		Details
Phenol with C12 alkylated branched olefin	-	-		R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health)		Details
Phenol, alkylation products (mainly in para position) with C12-rich branched alkyl chains from oligomerisation, covering any individual isomers and/ or combinations thereof (PDDP) show/hide Phenol, dodecyl-, branched EC / List no: 310-154-3 \| CAS no: 121158-58-5 Phenol, (tetrapropenyl) derivatives EC / List no: 616-100-8 \| CAS no: 74499-35-7 Phenol, tetrapropylene- EC / List no: - \| CAS no: 57427-55-1 [No public or meaningful name is available] EC / List no: - \| CAS no: 27459-10-5 Phenol, 4-dodecyl, branched EC / List no: 640-104-9 \| CAS no: 210555-94-5 Phenol, 4-isododecyl- EC / List no: 608-055-8 \| CAS no: 27147-75-7	799-972-3	-		R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health)		Details
Phenol, para alkylation products with C12-rich branched olefins from propene oligomerization	-	-		R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health)		Details
Plasmodium falciparum	-	-			P Parasites	Details
Plasmodium spp. (human and simian)	-	-			P Parasites	Details
Plesiomonas shigelloides	-	-			B Bacteria and similar species	Details
Polioviruses	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) RX-33	419-590-1	-	Flam. Sol. 1; Skin Sens. 1			Details
Porphyromonas spp.	-	-			B Bacteria and similar species	Details
potassium 3-iodo-6-methylbenzenesulfonate	426-300-5	-	Eye Dam. 1			Details
Potassium hydroxyoctaoxodizincatedichromate	-	-		C Carcinogenic (article 57a)		Details
potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate REAKTIVROT 2713	412-490-7	-	Skin Sens. 1			Details
potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat C.I. REACTIVE RED 231	402-150-6	-	Eye Irrit. 2; Skin Sens. 1			Details
potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)	425-830-4	-	Eye Dam. 1			Details
Powassan	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Prevotella spp.	-	-			B Bacteria and similar species	Details
Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt BROWN JR 547	419-260-5	-	Eye Dam. 1			Details
product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts sodium chloride	425-740-5	-	Eye Dam. 1			Details
Prospect Hill virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Proteus mirabilis	-	-			B Bacteria and similar species	Details
Proteus penneri	-	-			B Bacteria and similar species	Details

Prikazano 376 - 400 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 04 listopada 2024. Database contains 4917 unique substances/entries.

Footer Nav Items